Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach.
about
Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.High CYP2E1 activity correlates with hepatofibrogenesis induced by nitrosamines.Genetic variants of ALDH2-rs671 and CYP2E1-rs2031920 contributed to risk of hepatocellular carcinoma susceptibility in a Chinese population.
P2860
Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Changes in cytochrome P450s-me ...... in vivo: a bottom-up approach.
@en
Changes in cytochrome P450s-me ...... in vivo: a bottom-up approach.
@nl
type
label
Changes in cytochrome P450s-me ...... in vivo: a bottom-up approach.
@en
Changes in cytochrome P450s-me ...... in vivo: a bottom-up approach.
@nl
prefLabel
Changes in cytochrome P450s-me ...... in vivo: a bottom-up approach.
@en
Changes in cytochrome P450s-me ...... in vivo: a bottom-up approach.
@nl
P2093
P2860
P356
P1433
P1476
Changes in cytochrome P450s-me ...... in vivo: a bottom-up approach.
@en
P2093
Hai-Ling Qiao
Lin-Jing Jia
Xiao-Pei He
P2860
P304
28612-28623
P356
10.18632/ONCOTARGET.8704
P407
P577
2016-04-12T00:00:00Z